The IOI is currently home to 3 research programmes, with expertise spanning new drug discovery and target validation, and surveillance to understand the clinical and economic burden of AMR.

Researchers at the IOI are developing new drugs for human use and designing alternative antibiotics to use in agriculture and animal feed exclusively to reduce the threat of antimicrobial resistance globally. 

IOI’s research is guided by its global surveillance programmes in countries most affected by the threat of AMR including countries in Africa and South Asia.

Explore our research programmes in more detail below. 

Our capabilities

The IOI hosts a multidisciplinary research programme that is based on a wide range of capabilities that include AMR surveillance, the characterisation of mechanisms of drug resistance and modes of action of antibiotics, and drug discovery and development.